Psychometric Validation of the Chinese Version of the Atrial Fibrillation Knowledge Scale in Chinese Patients With Atrial Fibrillation

被引:3
|
作者
Li, Polly W. C. [1 ]
Yu, Doris S. F. [1 ]
Yan, Bryan P. P. [2 ]
Hendriks, Jeroen M. M. [3 ,4 ]
Wong, Cathy W. Y. [1 ]
Chan, Bernice S. S. [1 ]
机构
[1] Univ Hong Kong, LKS Fac Med, Sch Nursing, Pokfulam, 21 Sassoon Rd, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Hong Kong, Peoples R China
[3] Flinders Univ S Australia, Caring Futures Inst, Coll Nursing & Hlth Sci, Bedford Pk, SA, Australia
[4] Univ Adelaide, Royal Adelaide Hosp, Ctr Heart Rhythm Disorders, Adelaide, SA, Australia
关键词
atrial fibrillation; knowledge; psychometrics; reliability; validity; ORAL ANTICOAGULATION THERAPY; GLOBAL BURDEN; RISK; STROKE; PERCEPTIONS; PREVENTION; EDUCATION; ATTITUDE; IMPACT;
D O I
10.1097/JCN.0000000000000881
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundAssessment of patients' knowledge on atrial fibrillation (AF) and its management is important for evaluating their learning needs. However, a validated and comprehensive instrument to be used among Chinese patients is yet to be developed.ObjectivesThe aim of this study was to develop and validate the Chinese version of the Atrial Fibrillation Knowledge Scale (AFKS-C) in Chinese patients.MethodsThe 11-item AFKS was translated, and then content and face validations were conducted by an expert panel and patients with AF. A sample of 255 patients with AF was recruited from a university-affiliated hospital to evaluate its psychometric properties. The internal consistency and test-retest reliability were evaluated using the Kuder-Richardson formula 20 and kappa statistics. Item analysis determined the item difficulty index and item discrimination coefficients. Factorial and discriminant validity were evaluated using exploratory factor analysis and the known-groups method.ResultsThe content validity index of the AFKS-C was 0.94, and the Kuder-Richardson formula 20 value was 0.60. The difficulty indices of the items ranged from 0.36 to 0.89, and the point-biserial coefficients of the items ranged from 0.122 to 0.255, indicating sufficient discriminatory ability. The test-retest reliability was acceptable, because the kappa values ranged from 0.234 to 0.710. The principal axis factoring analysis indicated a 3-factor structure that explained 50.4% of the total variance. The AFKS-C also demonstrated satisfactory discriminant validity, having yielded significantly different scores between patients with newly diagnosed and established AF.ConclusionThe AFKS-C has acceptable psychometric properties and can be used to measure the knowledge of patients and evaluate the effects of patient education programs.
引用
收藏
页码:92 / 100
页数:9
相关论文
共 50 条
  • [21] Embolic events in 93 elderly Chinese patients with atrial fibrillation
    曹雪滨
    王士雯
    江龙安
    刘玲玲
    黄河玲
    吕增春
    中华医学杂志(英文版), 2000, (04) : 32 - 35
  • [22] Embolic events in 93 elderly Chinese patients with atrial fibrillation
    Cao, XB
    Wang, SW
    Jiang, L
    Liu, LL
    Huang, HL
    Lu, ZC
    CHINESE MEDICAL JOURNAL, 2000, 113 (04) : 320 - 323
  • [23] Catheter ablation for atrial fibrillation: The Chinese experience
    Cheng, Tsung O.
    Guo, Jihong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 111 (01) : 154 - 154
  • [24] Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation
    Ma, Changsheng
    Wang, Huishan
    Liu, Shaowen
    Tang, Ribo
    Sun, Yihong
    Du, Xin
    Li, Jingjie
    Wu, Shulin
    Yao, Yan
    Sang, Caihua
    Chang, Dong
    Liang, Yan
    Han, Yaling
    Dong, Jianzeng
    Jiang, Chenyang
    Ding, Yansheng
    Yu, Bo
    Wang, Yongjun
    Wang, Yan
    Wang, Zulu
    Wang, Ji-Guang
    Fang, Quan
    Yin, Xiaomeng
    Long, Deyong
    Fu, Hua
    Qu, Xiufen
    Liu, Shuwang
    Liu, Qiming
    Liu, Bin
    Liu, Jing
    Liu, Gang
    Jiang, Lisheng
    Jiang, Hong
    Tang, Baopeng
    Sun, Yingxian
    Li, Guangping
    Li, Shufeng
    Li, Xuebin
    Li, Shaolong
    Li, Shuyan
    Li, Yigang
    Yang, Yanzong
    Yang, Bing
    Yang, Jiefu
    Yang, Yanmin
    Yang, Xinchun
    He, Ben
    Zhang, Shuyang
    Zhang, Jian
    Zhang, Ping
    CARDIOLOGY DISCOVERY, 2024, 4 (02): : 89 - 133
  • [25] Chinese guidelines for the diagnosis and management of atrial fibrillation
    Ma, Changsheng
    Wu, Shulin
    Liu, Shaowen
    Han, Yaling
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2024, 47 (06): : 714 - 770
  • [26] Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation
    Ma, Chang-Sheng
    Wu, Shu-Lin
    Liu, Shao-Wen
    Han, Ya-Ling
    JOURNAL OF GERIATRIC CARDIOLOGY, 2024, 21 (03) : 251 - 314
  • [27] Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation
    Chang-Sheng MA
    Shu-Lin WU
    Shao-Wen LIU
    Ya-Ling HAN
    Journal of Geriatric Cardiology, 2024, 21 (03) : 251 - 314
  • [28] Angiotensinogen polymorphisms and acquired atrial fibrillation in Chinese
    Wang, Qun-shan
    Li, Yi-gang
    Chen, Xing-dong
    Yu, Jie-fei
    Wang, Jun
    Sun, Jian
    Lu, Shang-biao
    Jin, Li
    Wang, Xiao-feng
    JOURNAL OF ELECTROCARDIOLOGY, 2010, 43 (04) : 373 - 377
  • [29] Effect of family history of atrial fibrillation on recurrence after atrial fibrillation ablation: A report from the Chinese Atrial Fibrillation Registry Study
    Wu, Zhuanzhuan
    Jiang, Chao
    Li, Jingye
    Du, Jing
    Bai, Yu
    Guo, Xueyuan
    Wang, Wei
    Li, Songnan
    Jiang, Chenxi
    Liu, Nian
    Tang, Ribo
    Bai, Rong
    Sang, Caihua
    Long, Deyong
    Du, Xin
    Ma, Changsheng
    Dong, Jianzeng
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2021, 32 (03) : 678 - 685
  • [30] Integrated Care of Atrial Fibrillation Using the ABC (Atrial fibrillation Better Care) Pathway Improves Clinical Outcomes in Chinese Population: An Analysis From the Chinese Atrial Fibrillation Registry
    Wang, Yu-Feng
    Jiang, Chao
    He, Liu
    Du, Xin
    Sang, Cai-Hua
    Long, De-Yong
    Tang, Ri-Bo
    Dong, Jian-Zeng
    Lip, Gregory Y. H.
    Ma, Chang-Sheng
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8